PRA International

Is there really a shortage of study volunteers?

Saturday, August 1, 2015

Patient recruitment remains one of the biggest challenges facing the clinical research enterprise today. Forward-thinking industry leaders recognize the need for rethinking the common view that pa­tient recruitment is difficult primarily due to a shortage of study volunteers. Instead, these experts believe the industry needs to focus the discussion on practices that limit access to clinical trials and how to build support sys­tems needed to better engage patient commu­nities and the public in clinical research.

[Read More]

CluePoints expands global team

Friday, February 28, 2014

CluePoints, a provider of Risk-Based Monitoring (RBM) solutions for clinical trials, has announced three new appointments to its global team. John Colby and Elizabeth Polvent join the company’s U.S business development team, fulfilling a key element in its strategy for growth, while CluePoints also welcomes Jean Stéphenne, president of the board of directors of GlaxoSmithKline Biologicals, as a member of its board.

[Read More]

Report: CRO market to top $30 billion by 2018

Monday, November 11, 2013

A new report by healthcare sector corporate finance and strategy specialist Results Healthcare says the CRO sector is seeing a recovery, driven by improved optimism across the biopharma industry, the sector’s largest customer group, where many key CRO customers are now at the tail end of multi-year patent cliffs and are stepping up investments into their pipelines, particularly products in late-stage development.

[Read More]